|Bid||31.10 x 800|
|Ask||32.27 x 1100|
|Day's Range||31.78 - 32.68|
|52 Week Range||28.58 - 61.69|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 11, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||72.11|
One of the world’s largest and most important industries is ripe for disruption, and an under-the-radar artificial intelligence firm is ready to try its luck
Progress continues on the company's work to develop a mental health treatment using a psychoactive drug therapy.
Clinical trial results expected this fall could send shares of these stocks screaming higher, or lower.